Abstract: Embodiments of the present systems and methods may provide techniques for two-factor authentication (2FA) that leverage voice assistant devices such as Google Home and Amazon Echo. For example, in an embodiment, a computer-implemented method of authentication may comprise receiving an authentication request for a user of a service, authenticating the user using two-factor authentication, wherein at least one factor of the two-factor authentication is audio, and validating the authentication request upon validation of both factors of the two-factor authentication.

Abstract: Methods and systems are described for multispectral, non-invasive, and real-time assessment to diagnose hemorrhaging and/or hypoxia through PA imaging through an acoustic window defined in a body, such as through transfontanelle PA imaging of a neonatal infant brain. Such methods and systems include transmitting a plurality of ultrasound (US) waves and light between the probe device and the acoustic window, converting, via the probe device, a plurality of reflected US waves and generated PA waves into a plurality of US and PA signals, displaying in real-time on an US machine communicatively coupled to the probe device one or more images of the brain or spinal cord through the acoustic window, such as the neonatal infant brain through the fontanelle, and diagnosing at least one of one or more hemorrhages and hypoxia in the neonatal infant brain at least partially based on the one or more images.

Abstract: A system of topographic patterns for the prevention of bacterial adhesion and biofilm formation. The patterns may be provided on the surfaces of certain devices that are prone to bacterial adhesion and biofilm formation, such as urinary catheters. To reduce bacterial adhesion and biofilm formation, and to remove existing biofilms, the patterns are induced to transform from a first topography to a second topography. For example, the surface patterns may be formed from a shape memory polymer and then heated to transform the patterns from the first topography to the second topography to dislodge bacteria and prevent fouling.

Abstract: Provided herein are screening methods that utilize transgenic nematodes exposed to heat shock conditions, such as agents that increase stability of F-actin. The transgenic nematodes used can be in a wild-type background, functionally deleted for OSG-1, or express human ARHGEF10 in an OSG-1 background. Such transgenic nematodes also express a fluorescent protein, such as GFP. Such methods are in some examples high throughput and automated. Also provided are recombinant nematodes and kits that can be used with such methods.

Abstract: Provided herein are compositions including oxotremorine (e.g., oxotremorine methiodide or Oxo-M) and 4-PPBP (e.g., 4-PPBP maleate). Also provided are methods of treating a connective tissue defect in a subject with oxotremorine and 4-PPBP. In addition, provided are scaffolds and methods of making same that include multiple fibers that include Oxo-M, 4-PPBP, and optionally icariin or kartogenin.

Abstract: The present invention relates to methods and a kit for enhancing the translation ability of an RNA molecule. The methods involve the use of an RNA molecule comprising a methylated adenosine residue in a 5? untranslated region (UTR). Also disclosed are methods for eIF4E-independent translation of an RNA molecule and treatment methods.

Abstract: Slotted Aloha-NOMA (SAN) protocol is an uncoordinated, non-orthogonal, random access protocol that exploits the simplicity of SA (Slotted Aloha) and the superior throughput of non-orthogonal multiple access (NOMA) and its ability to resolve collisions via use of successive interference cancellation (SIC) receiver. In SAN protocol, the SIC receiver at the IoT gateway adaptively learns the number of active devices (which is not known a priori) using multiple hypothesis testing in order to successfully distinguish between signals transmitted from different IoT devices.

Abstract: The present invention is directed to therapeutic compositions targeting the NCCa-ATP channel of an astrocyte, neuron or capillary endothelial cell and methods of using same. More specifically, agonists and antagonists of the NCCa-ATP channel are contemplated. The therapeutic compositions are used to treat cancer, more specifically, a metastatic brain tumor, wherein a tumor-brain barrier is present. Such treatments are contemplated in combination with conventional anti-cancer therapies. Alternatively, the compositions are used to prevent cell death and to treat cerebral edema that result from ischemia, due to interruption of blood flow, to tissue trauma or to increased tissue pressure.

Abstract: The invention provides an evaluation method capable of objectively evaluating average visual perception for a comparatively long period of time when a subject looks through an eyeglass lens to be evaluated, time-dependent change in visual perception, and visual perception when looking with both eyes, and the invention provides a design method, and the invention provides a calculation method for calculating characteristics of visual perception of the subject when viewing an object through a lens.

Abstract: The present invention relates to the prevention and/or treatment of ADA-SCID, in a patient.

Abstract: The present application provides a method for simultaneously synthesizing a biological flocculant with polysaccharide and ?-PGA as the active components by using Bacillus licheniformis. Bacillus licheniformis is inoculated to a slant culture medium to be cultured; a single colony on a fresh plate is inoculated to a seed culture medium to be cultured; and a seed fermentation broth is inoculated to a fermentation culture medium to be cultured, and then the biological flocculant having two different components is obtained. The flocculant synthesized in the present invention is high in activity and good in thermal stability; and especially, the flocculation effect of polysaccharide is relatively superior under acidic and neutral conditions, and the flocculation activity of ?-PGA is relatively higher under neutral and alkaline environments, which can satisfy a relatively large pH application range.

Abstract: The present invention includes compositions and methods for treating diseases or disorders associated with pathological calcification or pathological ossification. In certain embodiments, the diseases or disorders are selected from the group consisting of Generalized Arterial Calcification of Infancy (GACI), Idiopathic Infantile Arterial Calcification (IIAC), Ossification of the Posterior Longitudinal Ligament (OPLL), hypophosphatemic rickets, osteoarthritis, calcification of atherosclerotic plaques, PXE, hereditary and non-hereditary forms of osteoarthritis, ankylosing spondylitis, hardening of the arteries occurring with aging, calciphylaxis resulting from end stage renal disease and progeria.

Abstract: A nanoparticle composition comprising a substrate comprising a metal oxide component and an aluminum oxide component; and a metallocene olefin polymerization catalyst component coupled to the substrate is disclosed. The metal oxide component is homogenously dispersed throughout the nanocomposite composition.

Abstract: The present disclosure relates to a new scan technique for particle radiation therapy that may be used for cancer treatment. One embodiment relates to a method of mitigating interplay effect in particle radiation therapy in a moving target including a period of movement, where the particle radiation therapy defines a planned dose in each spot of each layer of the moving target. The method comprising dividing the planned dose in each spot into a number of spot repaintings; and generating a scan pattern for each layer by defining a beam-on time at each spot for each spot repainting, and calculating a wait time between consecutive beam-on times to distribute the spot repaintings for each spot of a respective layer are distributed over a duration of an integer number of periods of movement.

Abstract: The present invention relates to the area of ATG4-related disorders. More particularly, the present invention relates to a method of treating an ATG4B-related disorder comprising a step of administering a subject with an effective amount of tioconazole. The present invention relates also to a method of increasing a subject's responsiveness to a therapy for a cancer comprising inhibition of ATG4B activity in cells; said method comprises administering the subject with an effective amount of tioconazole. The present invention also relates to a method for enhancing or inducing a response in a cancer cell consisting of cytotoxicity, chemosensitivity or starvation-sensitivity; said method comprises administering a subject with an effective amount of tioconazole to inhibit ATG4B's activity.

Abstract: Various examples are provided for radio frequency (RF) switching. In one example, a RF switch includes a dual-drive Mach-Zehnder modulator (DDMZM) that can generate a single-sideband (SSB) signal by modulating an input RF signal onto an optical carrier; a tunable phase modulator incorporated loop mirror filter (PM-LMF) that can optically notch filter the SSB signal in response to a control signal; and a photodetector (PD) that can generate a RF output signal based upon the SSB signal. In another example, a method includes modulating an input RF signal onto an optical carrier to generate a SSB signal; notch filtering the SSB signal by a tunable PM-LMF in response to a control signal; and generating a RF output signal based upon the SSB signal.

Abstract: Systems, methods and related devices used to produce and collect polarized noble gas to inhibit, suppress, detect or filter alkali metal nanoclusters to preserve or increase a polarization level thereof. The systems can include a pre-sat chamber that has an Area Ratio between 20 and 500.

Abstract: The disclosure provides for compounds having immunoproteasome inhibitory activity, and pharmaceutical compositions made thereof. The disclosure further provides for the use of the compounds and compositions in treating various diseases and disorders in a subject that are associated with immunoproteasome activity, including inflammatory disorders, autoimmune disorders, hematological disorders, and neurodegenerative disorders.

Abstract: Methods of making blended, isoporous, asymmetric (graded) films (e.g. ultrafiltration membranes) comprising two or more chemically distinct block copolymers and blended, isoporous, asymmetric (graded) films (e.g. ultrafiltration membranes) comprising two or more chemically distinct block copolymers. The generation of blended membranes by mixing two chemically distinct block copolymers in the casting solution demonstrates a pathway to advanced asymmetric block copolymer derived films, which can be used as ultrafiltration membranes, in which different pore surface chemistries and associated functionalities can be integrated into a single membrane via standard membrane fabrication, i.e. without requiring laborious post-fabrication modification steps. The block copolymers may be diblock, triblock and/or multiblock mixes and some block copolymers in the mix may be functionally modified. Triblock copolymers comprising a reactive group (e.g.

Abstract: Disclosed are derivative compounds of ELQ-300 that include an ester at position 4. These compounds have enhanced properties relative to ELQ-300. Also disclosed are pharmaceutical compositions comprising the compounds and methods of treating and preventing malaria infections involving administering the pharmaceutical compositions to the subject.